Key result
Multiple experts contest the claim that angiotensin receptor blockers increase the risk of myocardial infarction, arguing that the evidence relies on indirect comparisons and selective data citation.
Answers are grounded in this paper and cite their sources.
ARBs need not be avoided over MI concerns; leaves open need for direct comparative trials.
All authors have been or are involved in clinical trials with angiotensin receptor blockers in cardiovascular disease and have received honorariums for speaking, consultancy fees, and research
No takes yet. Share an insight, caveat, or question.
British Medical Journal Publishing Group (2005) conducted a letter in Myocardial infarction and cardiovascular disease. Angiotensin receptor blockers vs. ACE inhibitors or placebo was evaluated. Multiple experts contest the claim that angiotensin receptor blockers increase the risk of myocardial infarction, arguing that the evidence relies on indirect comparisons and selective data citation.
Synapse has enriched 10 related papers. Consider them for comparative context: